8:08AM Alimera Sciences: U.K.'s National Institute for Health and Clinical Evidence accepts ALIM's ILUVIEN subgroup data for review (ALIM) 2.33 : Co announced that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) has accepted for consideration additional data in the form of an appendix to Alimera's comments on the preliminary Appraisal Consultation Document previously issued by NICE for the ILUVIEN Single Technology Appraisal.
Market Data 
Markets 
